Login

Insider Transactions

What Aptose Biosciences Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 0
Total trades 9 9

Shares traded

3 months 12 months
Acquired 0 0
Disposed 631,979 631,979
Net activity −631,979 −631,979

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Bejar Rafael Insider Jun 30 Disposition to Issuer · D −244 $1.72 −$420 0
Burger Denis R Insider Jun 30 Disposition to Issuer · D −70 $1.72 −$120 0
Payne Fletcher Insider Jun 30 Disposition to Issuer · D −22 $1.72 −$37.8 0
Payne Fletcher Insider Jun 30 Disposition to Issuer · D −222 $1.72 −$382 0
Platzer Erich Insider Jun 30 Disposition to Issuer · D −1,122 $1.72 −$1.93K 0
Rice William G. Chair, President & CEO Jun 30 Disposition to Issuer · D −613,252 $1.72 −$1.05M 0
Whitehead Warren Insider Jun 30 Disposition to Issuer · D −33 $1.72 −$56.8 0
Seizinger Bernd R. Insider Jun 30 Disposition to Issuer · D −17,000 $1.72 −$29.2K 0
Vincent Mark D. Insider Jun 13 Disposition to Issuer · D −14 $1.72 −$24.1 0
Rice William G. Chair, President & CEO Nov 25 Open-market buy · P +100,000 $0.20 +$20K 613,252
Seizinger Bernd R. Director Sep 22 Open-market buy · P +17,000 $3.14 +$53.4K 17,000
Ledru Philippe Chief Commercial Officer Jan 19 Grant / award · A +100,000 100,500
Bejar Rafael Sr. VP, Chief Medical Officer Jan 19 Grant / award · A +100,000 110,000
Payne Fletcher SR VP & Chief Fin. Officer Jan 19 Grant / award · A +100,000 100,000
Rice William G. Chair, President & CEO Jan 19 Grant / award · A +150,000 513,252
Payne Fletcher SR VP & Chief Fin. Officer Sep 19 Open-market buy · P +10,000 $0.68 +$6.78K 10,000
Rice William G. Chair, President & CEO Sep 19 Open-market buy · P +10,000 $0.68 +$6.83K 363,252
Rice William G. Chair, President & CEO Jun 06 Open-market buy · P +10,000 $0.97 +$9.68K 353,252
Rice William G. Chair, President & CEO Dec 16 Open-market buy · P +13,183 $1.52 +$20K 343,252
Platzer Erich Director Dec 16 Open-market buy · P +20,000 $1.40 +$28K 505,000

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support